Changes in proinflammatory and immunosuppressive cytokine levels from before to after treatment
| Cytokine, pg/mL . | Difference in cytokine levels (SD), n = 184 . | P value . |
|---|---|---|
| Proinflammatory | ||
| IL-Iβ | 15.3 (171.7) | .2278 |
| IL-6 | −21.4 (593.9) | .6258 |
| TNF-α | −67.0 (1032.4) | .3796 |
| IFN-γ | 26.1 (103.5) | .0008 |
| IL-12 | 2.6 (33.4) | .2946 |
| IL-17a | 12.9 (78.1) | .0262 |
| MCP1_MCF | 113.9 (658.6) | .0201 |
| Immunosuppressive | ||
| IL-4 | 0.6 (4.6) | .0617 |
| IL-5 | 6.5 (67.3) | .1910 |
| IL-10 | −4.3 (32.2) | .0706 |
| IL-13 | −1.4 (6.8) | .0044 |
| Cytokine, pg/mL . | Difference in cytokine levels (SD), n = 184 . | P value . |
|---|---|---|
| Proinflammatory | ||
| IL-Iβ | 15.3 (171.7) | .2278 |
| IL-6 | −21.4 (593.9) | .6258 |
| TNF-α | −67.0 (1032.4) | .3796 |
| IFN-γ | 26.1 (103.5) | .0008 |
| IL-12 | 2.6 (33.4) | .2946 |
| IL-17a | 12.9 (78.1) | .0262 |
| MCP1_MCF | 113.9 (658.6) | .0201 |
| Immunosuppressive | ||
| IL-4 | 0.6 (4.6) | .0617 |
| IL-5 | 6.5 (67.3) | .1910 |
| IL-10 | −4.3 (32.2) | .0706 |
| IL-13 | −1.4 (6.8) | .0044 |
MCP1; monocyte chemoattractant protein-1); TNF-α, tumor necrosis factor α.
Bolded numbers are statistically significant.